Companies: 10,795·Total market cap: $144.5T
AVAX Technologies, Inc.

AVAX Technologies, Inc.

AVXTOTCHealthcare
$0.00
+$0.00(+0.00%)
Market Cap$6894
P/E Ratio
52W High$0.00001
52W Low$0.000001
Overview

AVAX Technologies, Inc. (AVXT) Shares Outstanding — Overview

Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.

AVXT · shares outstanding · updated Jun 9, 2026

Key metrics

Basic Shares Outstanding · Weighted average · fiscal year
118.9M +93.62% YoY Change
FY · as of Dec 31, 2007 · Reported in USD
vs 61.4M in FY 2006
Diluted Shares Outstanding
118.9M
incl. options, RSUs, convertibles
Dilution Spread
+0.00%
Diluted vs Basic
YoY Change
+93.62%
year-over-year
Float (Free Float)
684.0M
publicly tradable shares
99.2% of total
Source: FMP /income-statement · /shares-float · SEC 10-K / 10-QUpdated: 2026-06-09

Shares Outstanding Growth Rate

3-Year CAGRincreasing
+59.3%
2004 → 2007
5-Year CAGRincreasing
+48.4%
2002 → 2007
10-Year CAGRincreasing
+41.3%
1997 → 2007

Negative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials

Shares outstanding history

↓ Decrease — typically buyback / retirement
↑ Increase — issuance / equity compensation
Latest
* most recent reported · FMP /income-statement · weightedAverageShsOut

Annual shares outstanding by year

FY 2007Latest
Diluted Shares: 118.9M
118.9M
+93.62%
FY 2006
Diluted Shares: 61.4M
61.4M
+12.03%
FY 2005
Diluted Shares: 54.8M
54.8M
+86.40%
FY 2004
Diluted Shares: 29.4M
29.4M
+68.02%
FY 2003
Diluted Shares: 17.5M
17.5M
+5.81%
FMP /income-statement · weightedAverageShsOut · weightedAverageShsOutDilUnit: Billions (B)

Healthcare sector shares outstanding comparison

Shares Outstanding for similar companies or competitors in the Healthcare sector.

#SymbolCompanyShares (Basic)vs AVXT
#1
Merck & Co., Inc.MRK
Merck & Co., Inc.
2.502B+>999%
#2
Johnson & JohnsonJNJ
Johnson & Johnson
2.429B+>999%
#3
AbbVie Inc.ABBV
AbbVie Inc.
1.780B+>999%
#4
AstraZeneca PLCAZN
AstraZeneca PLC
1.550B+>999%
#5
UnitedHealth Group IncorporatedUNH
UnitedHealth Group Incorporated
910.0M+665.3%
#6
Eli Lilly and CompanyLLY
Eli Lilly and Company
898.0M+655.2%
#7
AVAX Technologies, Inc.AVXT
AVAX Technologies, Inc.YOU
118.9M

/company-screener · per-peer /income-statement · cache 86400s

Understanding Shares Outstanding

What Are Shares Outstanding? (Basic)

AVAX Technologies, Inc. (AVXT) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of December 31, 2007, AVAX Technologies, Inc. reports 118.9M basic shares outstanding (weighted average).

Basic vs. Diluted Shares Outstanding

AVAX Technologies, Inc.'s basic shares outstanding (118.9M) represents currently issued shares. Diluted shares outstanding (118.9M) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +0.00%.

Shares Outstanding vs. Float (Free Float)

AVAX Technologies, Inc.'s float is 684.0M (99.2% of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.

Float684.0M(99.2%)
Outstanding689.4M

Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.

FMP /income-statement · /shares-float · SEC EDGAR · USD

About shares outstanding & methodology

AVAX Technologies, Inc. (AVXT) shares outstanding history from 1996 to 2007. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.

AVAX Technologies, Inc. shares outstanding for the fiscal year ending December 31, 2007 were 118.9M, a 93.62% increase year-over-year. AVAX Technologies, Inc. FY 2007 shares outstanding were 118.9M, a +93.62% increase from FY 2006.

AVAX Technologies, Inc. is a leading company operating in the Healthcare sector. The company's share count trajectory — with a 10-year CAGR of +41.3% — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.

Figures tie to SEC 10-K/10-Q income statement disclosures and FMP /income-statement · /shares-float where noted.

Frequently asked questions

AVXT shares outstanding · 4 questions

As of December 31, 2007, AVAX Technologies, Inc. (AVXT) has approximately 118.9M basic shares outstanding and 118.9M diluted shares outstanding. This represents a +93.62% year-over-year increase from FY 2006 (61.4M). The increase may reflect equity compensation issuances or secondary offerings.

AVXT shares outstandinghow many shares does AVXT haveAVXT basic shares 2007AVXT diluted shares

Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · AVAX Technologies, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-09